In accordance with previous reports on the resistance of ER+ breast cancer cells, an indirect study by Li and collaborators showed that combinations of selenium and tamoxifen inhibit growth of ER+ breast cancer cells MCF7 in vivo by promoting apoptosis [38]. The gene discussed is ESR1; the disease is breast carcinoma.